Studies on the inhibition of pancreatic and carboxylester lipases by protamine.
The basic protein protamine strongly inhibited hydrolysis of triolein emulsified with soybean phosphatidylcholine (PC) by pancreatic and carboxylester lipases; 10 micrograms/ml protamine, about 1000 times lower than the concentration of bovine serum albumin for the same effect, inhibited triolein hydrolysis completely. This inhibition was not affected by the incubation pH or bile salt concentration. Two other basic proteins, histone and purothionin, also inhibited hydrolysis of triolein emulsified with soybean PC, but they did not inhibit triolein hydrolysis by gastric lipase. When gum arabic was used as an emulsifier instead of soybean PC, these basic proteins did not affect triolein hydrolysis by pancreatic or carboxylester lipases. The effects of protamine on triolein hydrolysis by pancreatic and carboxylester lipases was studied using various phospholipids as emulsifiers. Protamine (10 micrograms/ml) did not inhibit hydrolysis of triolein emulsified with dicaproyl PC (DCPC), phosphatidic acid (PA), or phosphatidylserine (PS) by pancreatic and carboxylester lipases. Conversely, protamine at high concentrations slightly stimulated hydrolysis of triolein emulsified with DCPC or PA. Hydrolysis of triolein-phosphatidylethanolamine (PE) emulsion was inhibited slightly by protamine. The profiles of protamine inhibition of triolein-phosphatidyl-N,N-dimethyl ethanolamine (PDME) and triolein-phosphatidyl-N-monomethyl ethanolamine (PMME) emulsions were intermediate between those of PC and PE emulsions. These results suggest that the phospholipid species, especially choline moieties and fatty acid chain length, affect the lipase inhibitory activity of protamine profoundly. In vivo, oral administration of protamine to rats reduced and delayed the peak plasma triacylglycerol concentration, but neither bovine serum albumin nor an amino acid mixture with an amino acid composition identical to protamine affected plasma triacylglycerol levels.
Tsujita
T
T
Department of Medical Biochemistry, School of Medicine, Ehime University, Japan.
Matsuura
Y
Y
Okuda
H
H
D000818:Animals; D023181:Antimicrobial Cationic Peptides; D043182:Carboxylesterase; D002265:Carboxylic Ester Hydrolases / Q000037:antagonists & inhibitors*; D004305:Dose-Response Relationship, Drug; D004791:Enzyme Inhibitors / Q000494:pharmacology; D005079:Excipients / Q000737:chemistry; D006170:Gum Arabic / Q000737:chemistry; D006657:Histones / Q000494:pharmacology; D006868:Hydrolysis; D066298:In Vitro Techniques; D008049:Lipase / Q000037:antagonists & inhibitors* / Q000378:metabolism; D008297:Male; D010179:Pancreas / Q000201:enzymology*; D010713:Phosphatidylcholines / Q000737:chemistry; D010940:Plant Proteins / Q000494:pharmacology; D011479:Protamines / Q000008:administration & dosage / Q000494:pharmacology*; D051381:Rats; D017208:Rats, Wistar; D012709:Serum Albumin / Q000494:pharmacology; D013656:Taurocholic Acid / Q000494:pharmacology; D014280:Triglycerides / Q000097:blood; D014304:Triolein / Q000737:chemistry
D023181:Antimicrobial Cationic Peptides; D004791:Enzyme Inhibitors; D005079:Excipients; D006657:Histones; D010713:Phosphatidylcholines; D010940:Plant Proteins; D011479:Protamines; D012709:Serum Albumin; D014280:Triglycerides; D014304:Triolein; D013656:Taurocholic Acid; D006170:Gum Arabic; C016085:purothionin; D002265:Carboxylic Ester Hydrolases; D043182:Carboxylesterase; D008049:Lipase